Your browser doesn't support javascript.
loading
Benralizumab: A novel treatment for the cutaneous features of paediatric eosinophilic granulomatosis with polyangiitis (pEGPA).
Bandla, M; Howard, M; McNally, A; Armstrong, D; Simpson, I; Mar, A.
Afiliação
  • Bandla M; Monash Medical Centre, Clayton, Victoria, Australia.
  • Howard M; Department of Dermatology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.
  • McNally A; Department of Dermatology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.
  • Armstrong D; Department of Respiratory and Sleep Medicine, Monash Medical Centre, Monash Health, Victoria, Clayton, Australia.
  • Simpson I; Department of Pathology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.
  • Mar A; Department of Dermatology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.
Australas J Dermatol ; 64(3): 404-407, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37195732
ABSTRACT
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis presenting primarily with pulmonary and cutaneous features. The disease is typically seen in the fifth or sixth decade of life (1, 2). We report a case of EGPA in an adolescent who was successfully treated with the interleukin-5 (IL-5) receptor inhibitor, benralizumab.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Churg-Strauss / Granulomatose com Poliangiite Limite: Adolescent / Child / Humans Idioma: En Revista: Australas J Dermatol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Churg-Strauss / Granulomatose com Poliangiite Limite: Adolescent / Child / Humans Idioma: En Revista: Australas J Dermatol Ano de publicação: 2023 Tipo de documento: Article